Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Refractory Macular Edema in Uveitis
NCT00498355Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 2007
- Primary completion
- Jan 2009
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in cystoid macular edema (CME), sponsored by University of California, San Francisco. Started Jul 2007; status: completed.
02
Drugs
ranibizumab
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT00498355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498355.